Bayer AG (BAYN) Given a €117.00 Price Target at Societe Generale

Societe Generale set a €117.00 ($136.05) target price on Bayer AG (FRA:BAYN) in a research report report published on Tuesday. The brokerage currently has a neutral rating on the healthcare company’s stock.

Other analysts also recently issued reports about the stock. UBS AG set a €125.00 ($145.35) price target on shares of Bayer AG and gave the stock a buy rating in a research report on Thursday, July 27th. Sanford C. Bernstein set a €128.00 ($148.84) price target on shares of Bayer AG and gave the stock a buy rating in a research report on Thursday, July 27th. equinet AG set a €118.00 ($137.21) price target on shares of Bayer AG and gave the stock a buy rating in a research report on Thursday, July 27th. Commerzbank Ag set a €126.00 ($146.51) price target on shares of Bayer AG and gave the stock a buy rating in a research report on Thursday, July 27th. Finally, J P Morgan Chase & Co restated a buy rating on shares of Bayer AG in a research report on Monday, July 24th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and fourteen have given a buy rating to the company. The stock has an average rating of Buy and an average price target of €122.43 ($142.36).

Bayer AG (FRA:BAYN) opened at €107.55 ($125.06) on Tuesday. Bayer AG has a one year low of €86.06 ($100.07) and a one year high of €123.82 ($143.98).

ILLEGAL ACTIVITY WARNING: “Bayer AG (BAYN) Given a €117.00 Price Target at Societe Generale” was first published by BBNS and is the property of of BBNS. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://baseballnewssource.com/markets/bayer-ag-bayn-given-a-117-00-price-target-at-societe-generale/1782247.html.

About Bayer AG

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, Crop Science, Animal Health, and Covestro segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

Analyst Recommendations for Bayer AG (FRA:BAYN)

Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with our FREE daily email newsletter.

 


Latest News

Seattle Mariners Start Offseason With a Bang: Three Trades Over Four Days
Seattle Mariners Start Offseason With a Bang: Three Trades Over Four Days
MLB Commissioner: New Rule for Pace-of-Play in 2018
MLB Commissioner: New Rule for Pace-of-Play in 2018
Alex Cobb Could Be Good Fit for Cubs
Alex Cobb Could Be Good Fit for Cubs
Joey Votto Is One of Baseball’s Best Hitters
Joey Votto Is One of Baseball’s Best Hitters
Hunter Pence May Become Part-Time Player
Hunter Pence May Become Part-Time Player
Perfect 300 Bowled by Red Sox Right Fielder Mookie Betts
Perfect 300 Bowled by Red Sox Right Fielder Mookie Betts


Leave a Reply

 
© 2006-2017 BBNS.